Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P E Kennedy

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
The Lamp|December 1, 1979
Ambulance paramedicP E Kennedy
American Journal of Hospital Pharmacy|February 1, 1991
Stability of amphotericin B in 5% dextrose injection at concentrations used for administration through a central venous lineP E Kintzel, P E Kennedy
American Journal of Hospital Pharmacy|August 1, 1991
Stability of amphotericin B in 5% dextrose injection at 25 degrees CP E Kintzel, P E Kennedy
Virology|January 1, 1993
Primary HIV-1 isolates refractory to neutralization by soluble CD4 are potently inhibited by CD4-Pseudomonas exotoxinP E Kennedy, B Moss, E A Berger
Journal of Medicinal Chemistry|February 1, 1984
Design, synthesis, and testing of potential antisickling agents. 3. Ethacrynic acidP E Kennedy, F L Williams, D J Abraham
Journal of Molecular Biology|October 15, 1983
Methylphenylmercury: a novel heavy atom reagent for protein crystallographyD J Abraham, S E Phillips, P E Kennedy
American Journal of Hospital Pharmacy|April 1, 1989
Stability of concentrated trimethoprim-sulfamethoxazole admixturesP F Jarosinski, P E Kennedy, J F Gallelli
Gene|May 16, 1994
Expression of foreign genes in cultured human primary macrophages using recombinant vaccinia virus vectorsC C Broder, P E Kennedy, F Michaels, et al.
Science (New York, N.Y.)|May 10, 1996
HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptorY Feng, C C Broder, P E Kennedy, et al.
Journal of Medicinal Chemistry|December 1, 1984
Design, synthesis, and testing of potential antisickling agents. 5. Disubstituted benzoic acids designed for the donor site and proline salicylates designed for the acceptor siteD J Abraham, D M Gazze, P E Kennedy, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
The Lamp|December 1, 1979
Ambulance paramedicP E Kennedy
American Journal of Hospital Pharmacy|February 1, 1991
Stability of amphotericin B in 5% dextrose injection at concentrations used for administration through a central venous lineP E Kintzel, P E Kennedy
American Journal of Hospital Pharmacy|August 1, 1991
Stability of amphotericin B in 5% dextrose injection at 25 degrees CP E Kintzel, P E Kennedy
Virology|January 1, 1993
Primary HIV-1 isolates refractory to neutralization by soluble CD4 are potently inhibited by CD4-Pseudomonas exotoxinP E Kennedy, B Moss, E A Berger
Journal of Medicinal Chemistry|February 1, 1984
Design, synthesis, and testing of potential antisickling agents. 3. Ethacrynic acidP E Kennedy, F L Williams, D J Abraham
Journal of Molecular Biology|October 15, 1983
Methylphenylmercury: a novel heavy atom reagent for protein crystallographyD J Abraham, S E Phillips, P E Kennedy
American Journal of Hospital Pharmacy|April 1, 1989
Stability of concentrated trimethoprim-sulfamethoxazole admixturesP F Jarosinski, P E Kennedy, J F Gallelli
Gene|May 16, 1994
Expression of foreign genes in cultured human primary macrophages using recombinant vaccinia virus vectorsC C Broder, P E Kennedy, F Michaels, et al.
Science (New York, N.Y.)|May 10, 1996
HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptorY Feng, C C Broder, P E Kennedy, et al.
Journal of Medicinal Chemistry|December 1, 1984
Design, synthesis, and testing of potential antisickling agents. 5. Disubstituted benzoic acids designed for the donor site and proline salicylates designed for the acceptor siteD J Abraham, D M Gazze, P E Kennedy, et al.
Pageof 3